期刊文献+

TNF-α对人脐静脉内皮细胞活性及PD-L1蛋白表达的影响 被引量:2

The effects of recombinant human TNF-α on the expression of programmed death-1 ligand-1 and proliferation of human umbilical vein endothelial cells
原文传递
导出
摘要 目的研究外源性肿瘤坏死因子α(TNF-α)对原代人脐静脉内皮细胞(HUVECs)活性及程序性死亡因子配体PD-L1蛋白表达的影响,探讨动脉粥样硬化的免疫机制。方法体外培养HUVECs,加入不同浓度TNF-α持续刺激48h,CCK-8法检测450nm波长处吸光度值(OD值),计算细胞生长存活率。选同代细胞重复培养并干预,Westernblot方法检测细胞PD-L1蛋白表达。使用SB203580阻断p38MAPK通路后再用TNF-α干预HUVECs,比较各组细胞PD-L1蛋白表达。结果实验组HUVECs在450nm波长处的吸光度值较空白对照组明显降低(P<0.05),细胞存活率依次下降。实验组细胞PD-L1蛋白表达随TNF-α浓度增高逐渐降低(P<0.05)。TNF-α单独刺激组PD-L1蛋白表达较TNF-α与SB203580共刺激组明显降低(P<0.05),SB203580阻断效应明显。结论 TNF-α可明显抑制HUVECs细胞活性,并降低PD-L1蛋白表达,p38MAPK通路可能参与了这一过程。 Objective This study aims to (i) investigate the effect of TNF-α on the expression of PD-L1 and on the proliferation of human umbilical vein endothelial cells (HUVECs), and (ii) study the immunopathogenesis of atherosclerosis. Methods HUVECs were incubated with various concentrations of TNF-α for 48 hours. Cell viability and proliferation were determined by CCK-8 assay. The protein of PD-L1 was analyzed by Western blotting. p38MAPK inhibitor SB203580 was added before TNF-α treatment. Results As the concentration of TNF-α increased from 5 ng / ml to 80 ng / ml, the OD value at 450 nm in the CCK-8 assay decreased significantly (P〈0.05). The expression of PD-L1 protein was suppressed by TNF-α significantly when compared with the control group (P〈0.05). The level of PD-L1 protein in TNF-α-treated group was lower than the normal group and TNF-α + SB203580 group (P〈0.05). Conclusion TNF-α was found to suppress the expression of PD-L1 and inhibit the proliferation of HUVECs. p38MAPK pathway may play a role in this process.
出处 《热带医学杂志》 CAS 2013年第6期691-694,F0002,共5页 Journal of Tropical Medicine
基金 广东省自然科学基金(10151051501000038)
关键词 肿瘤坏死因子Α PD-L1 P38MAPK 脐静脉内皮细胞 TNF-α PD-L1 p38MAPK human umbilical vein endothelial cells
  • 相关文献

参考文献14

  • 1Ross R. Atherosclerosis—an inflammatory disease [J]. N Engl JMed, 1999,340(2):115-126.
  • 2Biswas S, Ghoshal PK, Mandal SC, et al. Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction [J].Korean J Intern Med,2010,25 (1) : 44-50.
  • 3张赟,戴翠莲,姜黔峰.外源性肿瘤坏死因子-α刺激大鼠心脏MuRF-1表达[J].重庆医科大学学报,2011,36(1):1-4. 被引量:2
  • 4Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity[J]. Curr Opin Immunol, 2007,19(3) :309-314.
  • 5陈君,魏亚非,缪绯,武凯,刘映峰,孙茂本,江玲.冠心病患者外周血T淋巴细胞PD-L1的表达及意义[J].热带医学杂志,2011,11(3):257-259. 被引量:2
  • 6Bharadwaj D, Stein MP, Volzer M, et al. The major receptor forC-reactive protein on leukocytes is fcgamma receptor II [J]. J ExpMed, 1999,190(4): 585-590.
  • 7Lee J, Zhuang Y, Wei X,et al. Contributions of PD-1/PD-L1pathway to interactions of myeloid DCs with T cells inatherosclerosis[J]. J Mol Cell Cardiol, 2009,46(2) : 169-176.
  • 8刘芃,刘映峰,徐琳,李公信,赵欢,张紫微,缪绯.氧化低密度脂蛋白刺激内皮细胞程序性死亡配体-1的表达[J].实用医学杂志,2009,25(22):3737-3740. 被引量:5
  • 9Bocker W, Docheva D, Prall WC, et al. IKK-2 is required forTNF-alpha-induced invasion and proliferation of humanmesenchymal stem cells [J]. J Mol Med (Berl) , 2008,86 (10):1183-1192.
  • 10Esmon CT. Crosstalk between inflammation and thrombosis [J].Maturitas,2004,47(4):305-314.

二级参考文献64

  • 1张庆军,刘德培,梁植权.动脉粥样硬化的基础研究[J].中华医学杂志,2005,85(6):428-431. 被引量:32
  • 2钱桂生.在实践中提高对急性肺损伤和急性呼吸窘迫综合征新概念的认识[J].中国呼吸与危重监护杂志,2002,1(4):199-201. 被引量:33
  • 3戴翠莲,罗开良.蛋白酶体抑制剂MG-132对大鼠急性心肌缺血再灌注损伤的保护作用研究[J].重庆医科大学学报,2006,31(4):528-531. 被引量:7
  • 4戴翠莲,罗开良.蛋白酶体抑制剂MG-132下调炎症因子表达抑制大鼠心肌再灌注损伤[J].第三军医大学学报,2007,29(2):129-133. 被引量:7
  • 5Ester W A, Coena S, Peter H, et al. Protective role of endothelial nitric oxide synthase [ J]. J Pathol,2003,56( 1 ) :8 - 17.
  • 6Williams J K, Sukhova G K, Herrington D M, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys [J]. J Am Coll Cardiol, 1998,31 ( 3 ) : 684 - 91.
  • 7Laufs U, La Fata V, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors[ J]. Circulation,1998,97(12) :1129 -35.
  • 8Walter D H, Rittig K, Bahlmann F H. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells [ J ]. Circulation,2002,105 ( 25 ) : 3017 - 24.
  • 9Taro M, Ingela T, Majlis B ,et al. p38 MAPK kinasc negatively regulates endothelial cell survival, proliferation, and defferentiation in FGF2-stimulated [ J]. J Cell Biology,2002,156( 1 ) : 149 -60.
  • 10Ju H, Behu D J, Nerurkar S, et al. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1, p38MAPK-dependent endothelial dysfunction and hypertension[ J]. J Pharmacol Exp Ther,2003,307 (3) :932 - 8.

共引文献35

同被引文献7

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部